Takeda Pharmaceutical has lost a bid to limit claims in a
case accusing its predecessor Shire Plc of conspiring with
generic rival Actavis to delay launch of a generic version of
Shire's ADHD drug Intuniv through illegal patent settlements.
The 2nd U.S. Circuit Court of Appeals is expected to hear
arguments next week over whether to revive more than 900
lawsuits by women who said they developed a rare neurological
condition after using Bayer AG's Mirena contraceptive device.
A group of investors can examine Gilead Science Inc's books
and records for evidence of misconduct related to the marketing
of one of its leading HIV drugs, a Delaware judge has ruled,
castigating the company's "overly aggressive" defense and
suggesting it could be required to pay the investors' fees.
A federal judge has dismissed a shareholder lawsuit accusing
Salt Lake City, Utah-based biotech company PolarityTE Inc of
misleading investors about the prospects of its regenerative
skin tissue product.
Pfizer Inc unit Hospira's proposed generic version of Endo
International PLC's emergency allergy treatment Adrenalin would
infringe two of Endo's patents, a federal appeals court has
ruled, affirming a lower court ruling blocking the generic drug
from the market.
The 1st U.S. Circuit Court of Appeals on Friday upheld the
convictions and prison sentences of former Akebia Therapeutics
Inc and Merrimack Pharmaceuticals Inc employees who were found
to have taken part in an insider trading scheme.
A lawsuit accusing Merck & Co Inc of illegally stifling
competition for its rotavirus vaccine RotaTeq can proceed as a
class action, a Philadelphia federal judge has ruled, rejecting
the drugmaker's bid to send the case to arbitration a second
time after being directed by a U.S. appeals court to reconsider
Federal prosecutors have asked a judge to rule that Theranos
Inc founder Elizabeth Holmes and former chief operating officer
Ramesh "Sunny" Balwani cannot assert privilege over Theranos'
corporate documents in their criminal fraud case.
The maker of Tofurky meat substitute on Thursday urged a
federal appeals court to strike down a Missouri law making it a
crime to misrepresent a plant-based product as a meat product,
one of several similar state laws the company is fighting around
GlaxoSmithKline PLC has lost an appeal seeking to overturn
an $89.7 million verdict a jury handed down after finding that
the company's Ellipta line of inhalers infringed a patent
belonging to rival drug company Vectura Ltd.